APR 01, 2020 6:28 AM PDT

New Airway-Hugging Immune Cells Discovered in the Lung

WRITTEN BY: Tara Fernandez

Scientists have discovered a previously unknown subset of immune cells residing in the lung that specifically combat viral infections. The respiratory tract is particularly susceptible to invading viral pathogens, such as influenza, or SARS-CoV-2 (the virus that causes COVID-19).

Alveolar macrophages, or AMs, are the first line of cellular defense in the airways. These immune warriors deal with incoming infectious agents by “gobbling” them up through a process known as phagocytosis. They also secrete a cocktail of inflammatory chemicals known as cytokines, to recruit other immune cells to the site of potential infection. 

Scientists from Columbia University Medical Center recently found a distinct subset of AMs: nerve and airway associated macrophages, or NAMs. From their studies in mice, the group observed that this particular group of cells played a central role in dampening inflammatory responses during viral infections, in order to prevent damage to the respiratory system as a result of chronic inflammation.

 

 

As part of their investigation, the team exposed mice to the influenza virus to determine the cellular and biochemical processes orchestrated by airway-hugging NAMs during infection. This revealed a fascinating interplay between AMs and NAMs — while AMs primarily got rid of the virus, NAMs helped to keep infection-induced inflammation in check. 

Mapping the complex inflammatory cascades triggered by viral infections can provide valuable insights for creating treatments to manage respiratory infections like COVID-19.

The corresponding author of the study published in Science Immunology, Professor Kamal M. Khanna, said: “I think what excites me most about our findings is the fact that we have identified a unique subset of the macrophage population (a critical cell type of the innate immune system) that we know very little about. Our results provide essential insights into the development and maintenance and functions of a poorly understood subset of resident macrophages in the lung.”


Sources: Technology Networks, Science Immunology.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, ...
MAR 06, 2020
Drug Discovery & Development
MAR 06, 2020
Scorpion-derived Proteins Deliver Arthritis Treatment
New research published in the journal Science Translational Medicine shows that that a scorpion-derived proteins could s ...
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Could a 1949 Malaria Drug Treat COVID-19?
In the race to halt the current coronavirus pandemic, scientists, health experts and even Elon Musk are considering chlo ...
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 21, 2020
Cancer
APR 21, 2020
Scientists develop tumor immunity map
A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecule ...
Loading Comments...